ARMATA PHARMACEUTICALS, INC. REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • February 13th, 2020 • Armata Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • Delaware
This Registration Rights Agreement (this “Agreement”) is made and entered into as of February 12, 2020, by and between Armata Pharmaceuticals, Inc., a Washington corporation (the “Company”), and Innoviva, Inc. (the “Holder”). The Company and the Holder are referred to each as a “Party” and collectively herein as the “Parties.”
INVESTOR RIGHTS AGREEMENTInvestor Rights Agreement • February 13th, 2020 • Armata Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • Delaware
This Investor Rights Agreement (this “Agreement”) is made and entered into as of February 12, 2020 by and between Armata Pharmaceuticals Inc., a Washington corporation (the “Company”), and Innoviva, Inc., a Delaware corporation (the “Purchaser”), in connection with that certain Securities Purchase Agreement, dated as of January 27, 2020, by and between the Company and the Purchaser (the “Purchase Agreement”). Capitalized terms used herein have the respective meanings ascribed thereto in the Purchase Agreement unless otherwise defined herein.
